Translational control of gene expression in normal human cells and in pathological conditions

We are interested in the study of posttranscriptional regulation of gene expression. It is currently estimated that translation controls a large portion of gene expression by restricting protein synthesis to specific mRNAs. We have isolated eIF6, an initiation factor that regulates metabolism at the level of translation, and it is rate-limiting for cellular growth. Multidisciplinary projects address the role of eIF6 in development and disease, and its activity in Shwachman Diamond Syndrome.
The study of translation is extended to human cells from the immune system and from several neoplastic diseases, including multiple myeloma and malignant mesothelioma. By combining cell biology, biochemistry and molecular biology, we aim at the definition of mechanistic steps of translational control that drive pathological phenomena and can become a therapeutic target.

Projects

  • Development of new models to study translation in human cancer cells and in the human immune system.
  • Definition of therapeutic targets in Shwachman Diamond Syndrome
  • Translational control of lipid metabolism

Team

Nome / NameRuolo / RoleEmail
Elisa ArsuffiFellowarsuffi@ingm.org
Giacomo D'andreaPhD Studentdandrea@ingm.org
Nicola ManfriniAssociate Professormanfrini@ingm.org
Annarita MiluzioLaboratory Technicianmiluzio@ingm.org
Sara RicciardiAssociate Professorricciardi@ingm.org
Kashefi BehradStudentkashefi@ingm.org
Vanja TadicPost Doctadic@ingm.org
Sidra AshgarPost Docashgar@ingm.org

Publications

INGM RESEARCH IS SUPPORTED BY